Podcasts about Plaque

Ecoutez Ça va beaucoup mieux avec Jimmy Mohamed du 11 juin 2026.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Marc-André Mongrain (Sors-tu?) et Louis-Philippe Labrèche (Le Canal auditif) accueillent en studio la bête de scène ARIANE ROY qui s'offrira son premier spectacle à la Place des Festivals lors des Francos de Montréal le samedi 13 juin 2026, ainsi que le programmateur des Francos Maurin Auxéméry qui nous partage ses coups de coeur de la prog cette année. Montage et réalisation par Kim Giroux. Production de Culture Cible, en collaboration avec l'Équipe Spectra.

Here’s what you missed this week on Two Ts in a Pod! See omnystudio.com/listener for privacy information.

Microplastics and Stroke Risk: What a Landmark 2024 Study Found Inside Human Arteries In 2024, a team of Italian researchers published a study in the New England Journal of Medicine that stopped the cardiovascular science community in its tracks. They found microplastics, tiny synthetic fragments embedded inside the carotid artery plaque of more than half the patients they examined. And the patients who had them faced more than four and a half times the risk of a serious cardiovascular event compared to those who didn’t. This isn’t a distant, theoretical risk. These are living people who had already been identified as having carotid artery disease, and plastics were found inside their arterial walls. For stroke survivors and those at elevated risk of stroke, this study raises important questions that the medical system has not yet caught up with. What the Research Found The study by Marfella et al., published in the New England Journal of Medicine (2024), enrolled 304 patients who were undergoing carotid endarterectomy, a surgical procedure to remove plaque from the carotid arteries. Researchers analysed the excised plaque for the presence of microplastics and nanoplastics. Their findings: 58% of patients had detectable levels of polyethylene, polyvinyl chloride (PVC), or polystyrene in their arterial plaque. This was not contamination from the surgical procedure; it was already there. Over a 34-month follow-up period, patients with microplastics in their plaque had a 4.53 times higher risk of a combined endpoint: non-fatal myocardial infarction, non-fatal stroke, or death from any cause. Inflammatory markers were significantly elevated in the microplastics-positive group. IL-18 and TNF-alpha proteins associated with systemic vascular inflammation were markedly higher in plaque samples that contained plastics. This suggests the mechanism is not simply physical obstruction, but an inflammatory cascade triggered by the presence of synthetic material in arterial tissue. What This Means for Stroke Survivors The carotid arteries are the primary conduits supplying oxygenated blood to the brain. Plaque accumulation in these vessels is one of the leading causes of ischaemic stroke, and carotid artery disease is a condition many stroke survivors are already living with. “The patients with microplastics in their plaque had a 4.53 times higher risk of stroke, heart attack, or death over the 34-month follow-up. That’s not a marginal finding. That’s a signal the research community needed to take seriously.” The NEJM study doesn’t yet tell us whether removing microplastic exposure after the fact reduces risk. It doesn’t confirm that healthy individuals with no existing carotid disease are accumulating plastics at the same rate. And it cannot tell us which plastic sources are most responsible because we’re exposed to microplastics through drinking water, food packaging, air, and a dozen other vectors simultaneously. But what it does tell us clearly and with high statistical significance is that microplastics in arterial plaque are associated with dramatically worse cardiovascular outcomes. What the Research Does Not Yet Tell Us Science at the frontier moves in one direction at a time. This study establishes association, not causation. It cannot yet answer: Whether people without existing carotid disease are accumulating microplastics at comparable rates. Whether reducing exposure actively reverses or slows plaque-associated risk. Which types of microplastics are most biologically harmful? Whether there will be a clinical screening tool for this in the near future. These are the questions the next generation of research will need to answer. In the meantime, it’s reasonable to act on what we do know. Practical Steps to Reduce Exposure No clinical screening currently exists for microplastics in arterial plaque. There is no blood test, no imaging, no biomarker that your GP can order today. What you can do is reduce your ongoing exposure, particularly through food and water contact with plastics. Evidence-informed steps worth discussing with your treating team: Use glass, stainless steel, or ceramic containers rather than plastic for food and drink storage. Avoid microwaving food in plastic containers; heat accelerates the leaching of plastic particles. Filter your drinking water; some filters (carbon block and reverse osmosis) reduce microplastic levels significantly. Reduce consumption of highly processed foods in plastic packaging. Bring this study to your vascular neurologist, cardiologist, or GP and ask whether it’s relevant to your personal risk profile. This is not a recommendation to take a supplement or start a treatment. It’s an invitation to have an informed conversation with the people responsible for your care using the best available evidence. If you found this useful, my book walks through the science of stroke recovery in the same evidence-first, no-hype way. Find it at recoveryafterstroke.com/book. Want to go deeper and support the channel? Join the community at patreon.com/recoveryafterstroke. The post Plastics in Your Arteries: The Stroke Risk Study You Must Know appeared first on Recovery After Stroke.

Le 12 mars dernier, Chong Woo Kim s’est fait poignardé à mort dans son dépanneur Fleur Bleue, rue Berri. Ça fait près de trois mois et une citoyenne qui avait l’habitude de fréquenter le dépanneur familial nous a écrit pour lui rendre hommage. Entrevue avec Marie-Josée Hudon, résidente du Plateau Mont-Royal. Regardez aussi cette discussion en vidéo via https://www.qub.ca/videos ou en vous abonnant à QUB télé : https://www.tvaplus.ca/qub ou sur la chaîne YouTube QUB https://www.youtube.com/@qub_radioPour de l'information concernant l'utilisation de vos données personnelles - https://omnystudio.com/policies/listener/fr

Lower triglycerides, lower remnant cholesterol, lower ApoB. Zero change in coronary artery plaque. A new clinical trial is forcing a bigger conversation about how we treat cardiovascular disease.The drug was Olezarsen, an APOC3 inhibitor. The blood work looked impressive. The heart scans did not. So why would lowering well-established cardiovascular risk factors fail to move the needle on plaque? Dr. Bret Scher argues there's a critical difference between what we want to fix and how we go about fixing it. Lowering a number with a drug is not the same as addressing the underlying metabolic dysfunction that caused that number to be high in the first place.In this video, you'll learn:What the Olezarsen trial actually showed and why the results matterWhy elevated triglycerides often signal deeper metabolic dysfunction and insulin resistanceHow this same drug-first thinking plays out in type 2 diabetes, hypertension, and weight managementWhy narrowing our focus to "fix the number" can keep us from healing the whole systemHow metabolic medicine reframes the conversation around root causesThis isn't an argument against medication. Responsible drug use has an important place in patient care. But the best outcomes come when we ask why a number is abnormal in the first place and what combination of lifestyle changes and targeted treatments will actually address it.

A 10h, ce lundi 1er juin 2026, les GG : Charles Consigny, avocat, Barbara Lefebvre, prof d'histoire-géo, et Laura Warton Martinez, sophrologue, débattent de : Attal veut faire une campagne positive, à côté de la plaque ?

In this AJNR Article Summary, Dr. Francis Deng reviews CTA-based Carotid Plaque-RADS and its role beyond stenosis grading. He explains the key imaging features that define plaque vulnerability, then highlights two AJNR studies showing that the system is learnable, reproducible, and clinically meaningful for predicting future stroke risk, especially in patients with only mild or moderate carotid stenosis. Visit the website to read the related articles. Carotid Plaque-RADS: Inter- and Intrareader Agreement and Learning Curve Analysis in CTA CTA-Based Carotid Plaque-RADS Classification Improves Risk Stratification for Ischemic Cerebrovascular Events

CardioNerds Dr. Joseph Kassab, Dr. Mariana Garcia-Arango, and Dr. Christopher Mason explore the technological revolution of Coronary CT Angiography (CCTA) with expert faculty Dr. Michael Gallagher. The discussion details how CCTA has evolved into a frontline diagnostic and preventive tool, moving beyond simple anatomy to incorporate physiology via CT-FFR and biology through AI-driven plaque quantification. The episode reviews landmark evidence like the SCOT-HEART and PROMISE trials, the nuances of CAD-RADS 2.0 reporting, and the emerging role of AI in monitoring treatment response and personalizing cardiovascular care. Critically, they also discuss some of the assumptions and limitations of these techniques. Stay tuned for a matching review article to be submitted to US Cardiology Review, the official Journal of CardioNerds. This episode was supported by an independent medical education grant from HeartFlow. All CardioNerds education is planned, produced, and reviewed solely by CardioNerds.  Enjoy this Circulation Paths to Discovery article to learn more about the CardioNerds mission and journey. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscripts here. CardioNerds Multimodality Cardiovascular Imaging PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll Pearls Shift in Paradigm: CCTA is no longer just an anatomic test; with some key limitations, it can provide anatomy, physiology (CT-FFR), and plaque biology (AI-CPA) in a single non-invasive scan. The “Power of Zero” vs. Plaque: While a normal CCTA has a >95% negative predictive value, future MIs often arise from non-obstructive plaque that traditional stress tests might miss. CAD-RADS 2.0 Utility: The addition of plaque burden modifiers (P1–P4) is a “game changer,” allowing clinicians to identify high-risk patients who need aggressive lipid-lowering despite having only mild stenosis. CT-FFR as a Virtual Stress Test: CT-FFR uses computational fluid dynamics to simulate blood flow, potentially reducing unnecessary invasive catheterizations by approximately 61% without sacrificing safety. Seeing the Invisible: AI-based quantitative plaque analysis (QCPA) can identify “subvisual” plaque and low-attenuation (lipid-rich) components that are the primary drivers of acute coronary syndromes. Show Notes How has the role of CCTA changed compared to traditional functional testing? Historically, stress testing answered “is there ischemia today?”, which often reflects late-stage disease. CCTA identifies disease across the entire spectrum, asking “is there atherosclerosis and how much plaque is present?”. Landmark evidence: SCOT-HEART showed a 41% relative risk reduction in MI at 5 years attributed to intensified preventive therapies, and PROMISE showed CCTA was better at selecting patients who truly needed invasive angiography. Diagnostic CCTA imaging depends on the protocol, contrast timing, heart rate, heart rhythm, breathholding, scanner quality, and several patient factors (obesity, prior stents, heavy calcification, complex bypass anatomy, and motion artifact all may limit imaging). “CCTA is exceptional for the right patient, with the right scanner, and the right team.” What are the key modifiers introduced in CAD-RADS 2.0, and why do they matter? CAD-RADS 2.0 moved beyond stenosis severity to include plaque burden (P0 to P4), high-risk plaque (HRP) features, and the presence of ischemia based on CT-FFR. It serves as a clinical decision support tool: a patient with mild (25-49%) stenosis but “extensive” (P4) plaque burden is considered high risk and warrants aggressive risk factor modification. How is CT-FFR calculated, and when is it most useful in clinical practice? CT-FFR uses resting CCTA data and computational fluid dynamics to create a 3D model of coronary flow during simulated maximal hyperemia. It is often used for intermediate lesions (40–90% stenosis) to predict if they are  ischemia-producing, guiding the decision whether to proceed with invasive angiography.  The assumptions necessary for this computational modeling may not apply well to patients with microvascular dysfunction, significant myocardial scar or prior infarction, or ventricular hypertrophy. Still, data indicate that CT-FFR performs similarly to PET in predicting hemodynamically significant lesions.  CT-FFR performs well at the extremes (either clearly normal or clearly abnormal). Accuracy dips, however, in the intermediate range (~0.75-0.80), where decision-making is most critical. In this grey zone, additional factors can help guide the approach, including the amount of myocardium supplied, translesional gradient, and plaque features.   CT-FFR has not been validated in distal segments, stented segments, heavily calcified coronary arteries, or in patients with severe aortic stenosis. Caution with CT-FFR should be utilized in very calcified coronary segments.  What is AI-based quantitative plaque analysis (QCPA), and what metrics are ready for clinical use? This is potentially a paradigm shift, moving away from stenosis-centric thinking to a more disease burden and plaque biology focus. QCPA uses deep learning algorithms to automatically segment the vessel wall and quantify plaque volume in mm³. Ready for “prime time” metrics include: Total Plaque Volume (TPV), non-calcified plaque volume, and Low-Attenuation Plaque (LAP) burden. Can serial CCTA be used to monitor the effectiveness of medical therapies like statins? While not yet a routine guideline-driven practice, trials like PARADIGM and EVAPORATE show that therapies can stabilize plaque; notably, CCTA is better for monitoring than CAC scores, which can be misleading as statins often increase plaque calcification as part of the stabilization process. There are no randomized trials that serial CCTAs improve outcomes. Cost and radiation exposure will be notable limitations. Serial scan timing, scan acquisition and interpretation standardization would be key. Dr. Gallagher notes that we are moving toward a world in which plaque burden may become a “treatment biomarker,” similar to tumor burden in oncology.  References 1. Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies: JACC State-of-the-Art Review. Abdelrahman KM, Chen MY, Dey AK, et al. Journal of the American College of Cardiology. 2020;76(10):1226-1243. doi:10.1016/j.jacc.2020.06.076. 2. Non-Invasive Imaging in Coronary Syndromes: Recommendations of the European Association of Cardiovascular Imaging and the American Society of Echocardiography, in Collaboration With the American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Edvardsen T, Asch FM, Davidson B, et al. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 2022;35(4):329-354. doi:10.1016/j.echo.2021.12.012. 3. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Gulati M, Levy PD, Mukherjee D, et al. Journal of the American College of Cardiology. 2021;78(22):e187-e285. doi:10.1016/j.jacc.2021.07.053. 4. Contemporary, Non-Invasive Imaging Diagnosis of Chronic Coronary Artery Disease. van der Bijl P, Gulati M, Saraste A, et al. Lancet (London, England). 2025;406(10519):2577-2587. doi:10.1016/S0140-6736(25)01586-7. 5. State of the Art: Evaluation and Medical Management of Nonobstructive Coronary Artery Disease in Patients With Chest Pain: A Scientific Statement From the American Heart Association. Slipczuk L, Blankstein R, Bucciarelli-Ducci C, et al. Circulation. 2025;152(23):e443-e466. doi:10.1161/CIR.0000000000001394. 6. Diagnostic Performance of Fractional Flow Reserve Derived From Coronary CT Angiography: The ACCURATE-CT Study. Li C, Hu Y, Jiang J, et al. JACC. Cardiovascular Interventions. 2024;17(17):1980-1992. doi:10.1016/j.jcin.2024.06.027. 7. Clinical Outcomes Based on Coronary Computed Tomography-Derived Fractional Flow Reserve and Plaque Characterization. Sato Y, Motoyama S, Miyajima K, et al. JACC. Cardiovascular Imaging. 2024;17(3):284-297. doi:10.1016/j.jcmg.2023.07.013. 8. Clinical Use of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve: Expert Consensus by an International Working Group. Tang CX, Leipsic JA, Nørgaard BL, et al. European Radiology. 2026;:10.1007/s00330-025-12313-6. doi:10.1007/s00330-025-12313-6. 9. Diagnostic accuracy of computed tomography–derived fractional flow reserve: a systematic review. Cook CM, Petraco R, Shun-Shin MJ, et al. JAMA Cardiol. 2017;2(7):803-810. Doi:10.1001/jamacardio.2017.1314 10. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). Nørgaard BL, Leipsic J, Gaur S, et al. J Am Coll Cardiol. 2014;63(12):1145-1155. Doi:10.1016/j.jacc.2013.11.043 11. Comparison of coronary computed tomography angiography, fractional flow reserve, and perfusion imaging for ischemia diagnosis. Driessen RS, Danad I, Stuijfzand WJ, et al. J Am Coll Cardiol. 2019;73(2):161-173. Doi:10.1016/j.jacc.2018.10.056. 12. 1-year outcomes of FFRCT-guided care in patients with suspected coronary disease: the PLATFORM study. Douglas PS, De Bruyne B, Pontone G, et al. J Am Coll Cardiol. 2016;68(5):435-445. Doi:10.1016/j.jacc.2016.05.057. 13. Comparison of an initial risk-based testing strategy vs usual testing in stable symptomatic patients with suspected coronary artery disease: the PRECISE randomized clinical trial. Douglas PS, Nanna MG, Kelsey MD, et al; PRECISE Investigators. JAMA Cardiol. 2023;8(10):904-914. Doi:10.1001/jamacardio.2023.2595. 14. Diagnostic and clinical value of FFRCT in stable chest pain patients with extensive coronary calcification: the FACC study. Mickley H, Veien KT, Gerke O, et al. JACC Cardiovasc Imaging. 2022;15(6):1046-1058. doi:10.1016/j.jcmg.2021.12.010. 15. Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART). Williams MC, Kwiecinski J, Doris M, et al. Circulation. 2020;141(18):1452-1462. doi:10.1161/CIRCULATIONAHA.119.044720. 16. AI-Guided Quantitative Plaque Staging Predicts Long-Term Cardiovascular Outcomes in Patients at Risk for Atherosclerotic CVD. Nurmohamed NS, Bom MJ, Jukema RA, et al. JACC. Cardiovascular Imaging. 2024;17(3):269-280. doi:10.1016/j.jcmg.2023.05.020. 17. Interaction of AI-Enabled Quantitative Coronary Plaque Volumes on Coronary CT Angiography, FFRCT, and Clinical Outcomes: A Retrospective Analysis of the ADVANCE Registry. Dundas J, Leipsic J, Fairbairn T, et al. Circulation. Cardiovascular Imaging. 2024;17(3):e016143. doi:10.1161/CIRCIMAGING.123.016143. 18. Prognostic Value of AI-Based Quantitative Coronary CTA vs Human Reader-Based Visual Assessment: Results From the CONFIRM2 Registry. van Rosendael A, Nakanishi R, Bax JJ, et al. JACC. Cardiovascular Imaging. 2026;19(3):345-359. doi:10.1016/j.jcmg.2025.09.021.13. Pericoronary Adipose Tissue as a Marker of Cardiovascular Risk: JACC Review Topic of the Week. Tan N, Dey D, Marwick TH, Nerlekar N. Journal of the American College of Cardiology. 2023;81(9):913-923. doi:10.1016/j.jacc.2022.12.021. 19. Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: Final Results of the EVAPORATE Trial. Budoff MJ, Bhatt DL, Kinninger A, et al. European Heart Journal. 2020;41(40):3925-3932. doi:10.1093/eurheartj/ehaa652. 20. Coronary CT Angiography Evaluation With Artificial Intelligence for Individualized Medical Treatment of Atherosclerosis: A Consensus Statement From the QCI Study Group. Schulze K, Stantien AM, Williams MC, et al. Nature Reviews. Cardiology. 2026;23(2):100-115. doi:10.1038/s41569-025-01191-6.

In this special Memorial Day episode of The Chazz Palminteri Show, Chazz is surprised by producer John (NYVideoGuy) with the official YouTube Silver Play Button celebrating 100,000 subscribers. Chazz reflects on how the podcast began during COVID and thanks the audience for supporting the show's growth over the years. The episode then revisits a classic conversation with neighborhood legend Raffy “Squiggy” Squalante, who shares unforgettable stories about old-school Bronx life, gambling culture, bookmakers, neighborhood characters, and the realities of growing up in a very different New York. Blending humor, nostalgia, and authentic storytelling, this episode captures the spirit of old-school neighborhood culture and the importance of preserving these stories.

On this special industry sponsored episode, host Praveen Ranganath, MD is again joined by the esteemed Amir Ahmadi, MD, FSCCT to discuss the shift from "CT 1.0" to "CT 2.0" and eventually to "CT 3.0". Topics covered include CT-based coronary lesion-level assessment, normalizing plaque analyses, serial coronary CT imaging, reproducibility error margins, and the heart-brain axis. Tune in and enjoy!This episode is sponsored by Elucid. References to a specific product, process, or service by speakers in this podcast episode do not constitute or imply an endorsement by the Society of Cardiovascular Computed Tomography. The views and opinions expressed in do not necessarily reflect those of the Society of Cardiovascular Computed Tomography.

In this episode of Curiosity Killed the Plaque, Spring Hatfield, RDH, BSPH, looks at synovial chondromatosis of the TMJ, a rare, mostly benign, aggressive metaplastic change in the synovial membrane.Like this show? Leave us a review on your favorite podcasting app!Need CE? Start earning CE credits today at ⁠⁠⁠⁠https://rdh.tv/ce⁠⁠⁠⁠ Get daily dental hygiene articles at ⁠⁠⁠⁠https://www.todaysrdh.com⁠⁠⁠⁠ Follow Today's RDH on Facebook: ⁠⁠⁠⁠https://www.facebook.com/TodaysRDH/⁠⁠⁠⁠Follow Kara RDH on Facebook: ⁠⁠⁠⁠https://www.facebook.com/DentalHygieneKaraRDH/⁠⁠⁠⁠Follow Kara RDH on Instagram: ⁠⁠⁠⁠https://www.instagram.com/kara_rdh/⁠

Send us Fan MailIn the time it will take you watch this episode, over 2,000 people around the world will die from diseases driven by arterial plaque. But what if we could actually remove the toxic cholesterol already trapped inside arteries?Today we're diving into one of the biggest unsolved problems in medicine and aging: how do you actually remove arterial plaque instead of merely slowing its progression?Cardiovascular disease remains the world's leading killer, despite decades of statins, anti-inflammatory drugs, and newer RNA-based therapies. Most existing treatments help manage cholesterol and reduce risk, but very few directly target the toxic debris already embedded inside plaques.But what if we could literally extract some of the most dangerous oxidized cholesterol molecules from the body?My guest today is Dr. Matthew ‘Oki' O'Connor, Ph.D. - CEO and Co-Founder of Cyclarity Therapeutics ( https://cyclaritytx.com/ ), a biotech company developing engineered cyclodextrin molecules designed to bind and remove 7-ketocholesterol, or 7KC - a toxic oxidized cholesterol strongly implicated in atherosclerosis, inflammation, plaque instability, and even broader age-related diseases.Just recently, the company presented first-in-human clinical data at the American Heart Association Vascular Discovery Scientific Sessions showing dose-dependent urinary excretion of 7KC - potentially the first clinical evidence that this toxic molecule can be safely mobilized and removed from the human body.We'll discuss what 7KC actually is, why oxidized cholesterol may be a root driver of cardiovascular disease, how engineered cyclodextrins work like molecular “sponges,” what the new human data really shows - and what it would mean if medicine could move from slowing plaque progression to truly reversing it.#HeartDisease #Atherosclerosis #Longevity #CardiovascularDisease #PlaqueReversal #AgingResearch #Biotech #Cholesterol #OxidizedCholesterol #7Ketocholesterol #Cyclarity #Healthspan #PrecisionMedicine #AIinBiotech #DrugDiscovery #PreventiveMedicine #Cardiology #AntiAging #Lifespan #MedicalInnovation #SENS #FoamCells #Plaque #HeartAttack #StrokePreventionSupport the show

durée : 00:01:39 - L'info d'ici, ici Périgord Vous aimez ce podcast ? Pour écouter tous les autres épisodes sans limite, rendez-vous sur Radio France.

Nick Norwitz has an MD, a PhD, and a cholesterol level that should have killed him — at least according to the standard model of cardiovascular disease. For seven years, his total cholesterol held above 700. His LDL sat in the high 500s. Every clinical algorithm flagged him as a cardiac emergency. He took none of the prescribed medications.His just-published case report shows zero coronary plaque. Not reduced. Not minimal. Zero.This episode isn't a victory lap. It's a serious conversation about what that result means — for how medicine measures risk, how it handles outliers, and why the incentive structures that shape clinical decisions may be more dangerous than any single cholesterol number. Dr. Philip Ovadia and Nick Norwitz also go deep on a fraudulent case report published in Circulation, why statins suppress GLP-1 levels and almost no cardiologist knows it, and what happens when the patient who refuses to follow the algorithm turns out to be right.#metabolichealth #cholesterol #ketodiet #heartdisease #LDLcholesterol #evidencebasedmedicine #lowcarb #preventivecardiologyBIG IDEAA patient with seven years of astronomically high cholesterol and zero coronary plaque is not an outlier to dismiss — he is a question medicine is obligated to answer.Nick Norwitz Contact InfoNewsletter: staycuriousmetabolism.com (Top 2 Best-Selling in Science, Globally)YouTube: https://www.youtube.com/@nicknorwitzMDPhD (>1M Subscribers)Twitter: https://x.com/nicknorwitzInstagram: https://www.instagram.com/nicknorwitz/LinkedIn: https://www.linkedin.com/in/nicknorwitz/Threads: https://www.threads.net/@nicknorwitzFacebook: https://www.facebook.com/nicknorwitzNick's Case Report:Seven Years of 700 Cholesterol Without CoronaryAtherosclerosis: A Lean Mass Hyper-Responder Case ReportSend Dr. Ovadia a Text Message. (If you want a response, you must include your contact information.) Dr. Ovadia cannot respond here. To contact his team, please send an email to team@ifixhearts.com Order at Amazon: Stay Off My Kitchen Table  Like what you hear? Head over to IFixHearts.com/book to grab a copy of my book, Stay Off My Operating Table. Ready to go deeper? Talk to someone from my team at IFixHearts.com/talk.Ready to take control of your health?  Grab Dr. Ovadia's brand new book Stay Off My Kitchen Table now! This isn't just another diet book; it reveals why it's not just what you eat, but what your body actually absorbs that determines your health.If you're struggling with low energy, stubborn weight, or feeling like “healthy eating” isn't working… this book shows you exactly how to fix it.Learn how to reset your gutEliminate hidden foods sabotaging your progressUnlock real energy, metabolism, and longevityDon't wait until it's too late. Take action today. Get your copy of Stay Off My Kitchen Table now.Learn More:Take Dr. Ovadia's metabolic health quiz: iFixHearts Dr. Ovadia's website: Ovadia Heart HealthTheme Song : Rage AgainstWritten & Performed by Logan Gritton & Colin Gailey (c) 2016 Mercury Retro RecordingsAny use of this intellectual property for text and data mining or computational analysis including as training material for artificial intelligence systems is strictly prohibited without express written consent from Dr. Philip Ovadia.

In dieser Folge spreche ich mit Prof. Dr. med. Uwe Nixdorff, Internist, Kardiologe, Sportmediziner und Gründer des European Prevention Center (EPC) in Düsseldorf, über die Todesursache Nummer 1 in Europa: Herz-Kreislauf-Erkrankungen. Allein in Deutschland sterben jedes Jahr rund 345.000 Menschen am Herzinfarkt, und 60 bis 80 Prozent davon, bevor sie überhaupt im Krankenhaus ankommen. Gleichzeitig zeigen große Studien wie die Inter Heart Trial, dass sich rund 80 Prozent dieser Infarkte vermeiden ließen. Wir sprechen darüber, warum das klassische Belastungs-EKG für die Früherkennung längst nicht mehr ausreicht, was es mit der gefährlichen vulnerablen Plaque auf sich hat und warum nur moderne Bildgebung sie sichtbar macht. Prof. Nixdorff erklärt seinen evidenzbasierten Algorithmus, von der sorgfältigen Risikofaktoren-Anamnese über Pulswellenanalyse, Funduskopie und Age-Scan bis zum Herz-CT, das seit Kurzem auch von der Kasse für die Früherkennung anerkannt ist. Wir sprechen über Blutdruck-Zielwerte, die drei Säulen Bewegung, Ernährung und Entspannung, sinnvolle Wearables wie Continuous Glucose Monitoring und über die Frage, warum Selbstverantwortung in der Prävention so entscheidend ist. In dieser Folge sprechen wir u.a. über folgende Themen: - Warum die Letalität bei Herzinfarkt zurückgeht, die Morbidität aber steigt, und was das für den Healthspan bedeutet? - Was ist eine vulnerable Plaque, warum ist sie so tückisch und weshalb erkennt sie ein klassisches Belastungs-EKG nicht? - Wie sich die Pathophysiologie eines Herzinfarkts in zwei Minuten verstehen lässt, von Noxen über LDL-Oxidation bis zur Ruptur der Deckplatte? - Warum rund 80 Prozent der Herzinfarkte vermeidbar wären und was das für unser Gesundheitssystem bedeuten würde? - Welche Risikofaktoren laut Framingham und Inter Heart Trial wirklich zählen und welche Rolle psychosozialer Stress dabei spielt? - Warum der Body Mass Index nicht ideal ist und der Taillenumfang die deutlich aussagekräftigere Messgröße darstellt? - Was Pulswellenanalyse, Augmentationsindex und Pulswellengeschwindigkeit über die Arteriensteifigkeit verraten und welche dieser Werte reversibel sind? - Wie der Age-Scan über die Maillard-Reaktion sichtbar macht, was die Verzuckerung von Proteinen mit Atherosklerose zu tun hat? - Weshalb der Augenhintergrund einen arteriellen Hypertonus oft schon ein bis zwei Jahre vor der Manifestation anzeigt? - Wie sich Calcium-Scoring und kontrastmittelgestütztes Herz-CT unterscheiden und warum Letzteres den diagnostischen Herzkatheter weitgehend ersetzen kann? - Warum Stentimplantationen im stabilen Fall laut Studien wie ISCHEMIA und ORBITA prognostisch oft keinen Vorteil bringen? - Welche drei Lebensstil-Säulen die kardiologische Prävention tragen und welche Rolle Wearables wie CGM und Aura Ring dabei spielen? Weitere Informationen zu Prof. Dr. med. Uwe Nixdorff findest du hier: - https://kardiologie-nixdorff.de/ - https://www.epccheckup.de/ Du interessierst dich für Gesunde Langlebigkeit (Longevity) und möchtest ein Leben lang gesund und fit bleiben, dann folge mir auch auf den sozialen Kanälen bei Instagram, TikTok, Facebook oder YouTube. https://www.instagram.com/nina.ruge.official https://www.tiktok.com/@nina.ruge.official https://www.facebook.com/NinaRugeOffiziell https://www.youtube.com/channel/UCOe2d1hLARB60z2hg039l9g Disclaimer: Ich bin keine Ärztin und meine Inhalte ersetzen keine medizinische Beratung. Bei gesundheitlichen Fragen wende dich bitte an deinen Arzt/deine Ärztin. STY- 289

Walking into a cardiologist appointment is more often than not walking into a time machine. Not only the discussions about disproven risks but unfortunately the outdated tools and technology that have little to no predictive or preventative potential. The worst part is the technology exists that can identify to the microscopic level the type of plague actually causal to more than 80% of heart-attacks! That's what Dr Osborne and ClearCardio are doing right now.Dr. John Osborne is a cardiologist and the founding director of State of the Heart Cardiology, with a strong focus on preventive and non-invasive cardiovascular care. He holds an M.D. magna cum laude, a Ph.D. in cardiovascular physiology, and completed postdoctoral training at Harvard Medical School and Brigham and Women's Hospital. Uniquely board-certified across multiple disciplines, his work spans metabolic health, cardiovascular genetics, and advanced cardiac imaging. Dr. Osborne has received the American Heart Association's Cardiac Care Provider of the Year award. He is also the founder of ClearCardio™, where he is advancing proactive heart health through the use of AI-driven diagnostics and personalized care.Contact:Youtube - https://www.youtube.com/@ClearCardioWebsite - https://clearcardio.comJoin us as we explore:Why EKGs and CAC scores offer far less than advertised.Why so much that happens in a cardiologists office are 20th century tools, and why ClearCardio's cutting-edge AI biotech offers lifesaving  preventative potential.AI's ability to identify and quantify plague  to the 10th of a cubic millimeter!CT vs MR, the different types of arterial plague (hard, soft, lipid rich, active) , why 86% of heart attacks will never show up on your CAC scoreWhy strokes and heart disease are far more connected than appreciated, and how the cholesterol story has misguided us.Why blood markers like hsCRP are far more critical to understanding cardiovascular disease than even I appreciated.MentionsProduct - OMRON, https://omronhealthcare.com/products/evolv-wireless-upper-arm-blood-pressure-monitor-bp7000Test - Cleerly, https://cleerlyhealth.comSupport the showFollow Steve's socials: Instagram | LinkedIn | YouTube | Facebook | Twitter | TikTokSupport the show on Patreon:As much as we love doing it, there are costs involved and any contribution will allow us to keep going and keep finding the best guests in the world to share their health expertise with you. I'd be grateful and feel so blessed by your support: https://www.patreon.com/MadeToThriveShowSend me a WhatsApp to +27 64 871 0308. Disclaimer: Please see the link for our disclaimer policy for all of our content: https://madetothrive.co.za/terms-and-conditions-and-privacy-policy/

We are delighted to welcome Glenda Youde and Steve Kenyon who join us to share the details of a new Blue Plaque being unveiled in Matlock, Derbyshire. Celebrating the long stay of Dante Rossetti and Elizabeth Siddal in Lime Tree View, Glenda and Steve tell us about their time in Matlock and the fascinating history of the property. Please join them for the grand reveal on the 9th May 2026. For tickets, please visit: https://www.eventbrite.co.uk/e/dante-gabriel-rossetti-and-elizabeth-siddal-in-matlock-tickets-1984180310722 

Aujourd'hui, Antoine Diers, consultant auprès des entreprises, Didier Giraud, éleveur de bovins, et Fatima Aït Bounoua, prof de français, débattent de l'actualité autour d'Olivier Truchot.

durée : 00:11:25 - Les interviews d'Inter - par : Ali Baddou, Marion L'Hour - L'invitée 7h50 du week-end est Nadia Daam, journaliste et autrice qui publie son nouveau roman "Des filles comme il faut" (L'Iconoclaste). - invités : Nadia Daam Journaliste et écrivaine Vous aimez ce podcast ? Pour écouter tous les épisodes sans limite, rendez-vous sur Radio France

Part 1: Peter EastonIn the early 1600s, Peter Easton turned Newfoundland into something few would expect — a pirate stronghold. Operating out of Harbour Grace, Easton commanded a powerful fleet, raided ships across the Atlantic, and built a reputation that reached from England to the Mediterranean. For a time, he was nearly untouchable and earned the moniker ‘Pirate Admiral'. His presence on the island blurred the line between outlaw and authority figure.His story lives on in Newfoundland history, lore… and maybe maps.Part 2: Happy AdventureOn the Eastport Peninsula, Happy Adventure is a place with a name that practically begs for a story—and it has plenty. Some say it traces back to Peter Easton and his ship of the same name, while others point to a passing surveyor or the hopeful optimism of early settlers. Like much of Newfoundland's folklore, the truth is hard to pin down — it's lost somewhere between documented history and enthusiastic storytelling. Plaque in Happy Adventure, NLIn this segment, we dig into the competing origin stories behind the name, explore the landscape that may have inspired it, and follow the threads of pirate lore that run through the entire Eastport Peninsula. From “happy” adventures to more “damnable” ones, it's a reminder that even the smallest places can hold some of the biggest — and most exciting — stories.Part 3: Tammy Hynes & Adventure KnoxTammy L. Hynes is a Newfoundland-based writer and educator whose work spans fiction, history, and creative nonfiction. She is the author of The Adventure Knox series and the forthcoming Wells of Truth series. Her past publications also include A History of Renews and Politics of the Kitchen, a unique collection of recipes from some of Canada's most prominent politicians of the early 2000s. She has also contributed to the international bestseller How the Secret Changed My Life.Hynes is currently developing two Newfoundland-set fiction series: Adventure Knox, a young adult historical adventure series set in 1930s Newfoundland, and The Wells of Truth, an adult paranormal murder-mystery series. Blending historical fact with fiction, her writing brings Newfoundland's past and atmosphere to life for a broad range of readers.In this episode, we dive into the first book in her Adventure Knox series, The Summer of Secrets.The novel follows Tese Knox, a young teen with a knack for finding adventures, so much so either becomes her nickname. One summer in Renews, Newfoundland, Tese stumbles across clues suggesting that a centuries-old legend of buried pirate treasure might actually be true. But as she digs deeper, the mystery leads somewhere far more unexpected — uncovering threads of corruption tied to Newfoundland's former government, and igniting a sense of curiosity that reaches well beyond a single summer.Learn more about Tammy L. Hynes and get Adventure Knox: The Summer of SecretsAdventure Knox: The Summer of Secrets, Tammy L. Hynes at Amazon.caBeauty Beneath: Prequel to the Wells of Truth, Tammy L. Hynes at Amazon.caTammy L. Hynes at Facebook

Calcium Score to Evaluate Arterial Plaque; 50% of Statin Candidates May Not Need Them; Cholesterol Skepticism and Misunderstood Risk; Inflammation as a Key Risk Driver; Combining CRP and LDL for Better Risk Prediction; Why ApoB and Lipoprotein(a) Matter More Than LDL; Patient Case: High Lipoprotein(a) Despite Normal Cholesterol; Understanding Supplements: Red Yeast Rice and Berberine; Niacin: The Disappointing Heart Health Supplement; Amla (Indian Gooseberry) and Simvastatin Comparison; Health = Resilience ÷ Stress; Genetic Variability in Cholesterol Absorption from Food #HeartHealth #Cholesterol #LifestyleMedicine #HealthTalks

Commentary by Dr. Elvin Kedhi.

In this episode of Curiosity Killed the Plaque, Spring Hatfield, RDH, BSPH, questions if dentistry should rethink maxillary teeth innervation.Like this show? Leave us a review on your favorite podcasting app!Need CE? Start earning CE credits today at ⁠⁠⁠⁠⁠https://rdh.tv/ce⁠⁠⁠⁠⁠ Get daily dental hygiene articles at ⁠⁠⁠⁠⁠https://www.todaysrdh.com⁠⁠⁠⁠⁠ Follow Today's RDH on Facebook: ⁠⁠⁠⁠⁠https://www.facebook.com/TodaysRDH/⁠⁠⁠⁠⁠Follow Kara RDH on Facebook: ⁠⁠⁠⁠⁠https://www.facebook.com/DentalHygieneKaraRDH/⁠⁠⁠⁠⁠Follow Kara RDH on Instagram: ⁠⁠⁠⁠⁠https://www.instagram.com/kara_rdh/⁠

Ready for your personalized care plan? Call us Now: 859-721-1414 or visit http://www.prevmedcare.com/sp1 Get My 7- Step Heart Attack Prevention Protocol free ebook here: https://45413573.hs-sites.com/ebook Unlock Your Exclusive Discount Offer & Bonus eBook—Today!https://www.prevmedcare.com/glucose-manager

Dylan Gemelli went from prison to Milan runways to millions of YouTube subscribers — and then a calcium score of 120 and an LP(a) of 330 stopped him cold at 40 years old. In this conversation with Dr. Philip Ovadia, he breaks down what both the biohacking and conventional medical worlds are getting wrong, why confusion is the real enemy of public health, and how he dropped his LP(a) from 330 to 94 without following his doctor's orders. This episode is equal parts cardiovascular science and hard-won life philosophy — and the two turn out to be inseparable.BIG IDEAIf you're not right spiritually, I don't care what anybody says — it's going to be a struggle to fix the other two.Dylan Gemelli Contact info:InstagramDylan Gemelli Biohacking on YouTubeThe Dylan Gemelli PodcastDylan's WebsiteSend Dr. Ovadia a Text Message. (If you want a response, you must include your contact information.) Dr. Ovadia cannot respond here. To contact his team, please send an email to team@ifixhearts.com Pre-Order Stay Off My Kitchen Table at Amazon. Like what you hear? Head over to IFixHearts.com/book to grab a copy of my book, Stay Off My Operating Table. Ready to go deeper? Talk to someone from my team at IFixHearts.com/talk.Stay Off My Operating Table on X:   Dr. Ovadia: @iFixHeartsJack Heald: @JackHeald5Learn more:Stay Off My Operating Table on AmazonTake Dr. Ovadia's metabolic health quiz: iFixHearts Dr. Ovadia's website: Ovadia Heart HealthJack Heald's website: CultYourBrand.comTheme Song : Rage AgainstWritten & Performed by Logan Gritton & Colin Gailey(c) 2016 Mercury Retro RecordingsAny use of this intellectual property for text and data mining or computational analysis including as training material for artificial intelligence systems is strictly prohibited without express written consent from Dr. Philip Ovadia.

Aujourd'hui, Barbara Lefebvre, enseignante, Abel Boyi, éducateur, et Antoine Diers, consultant auprès des entreprises, débattent de l'actualité autour d'Alain Marschall et Olivier Truchot.

Wrestling legend Kevin Nash and co-host Sean Oliver return for another installment of Kliq This, where the conversation flows as freely as the wine they frequently discuss. In episode 197, titled "Clarity," the duo leans into their "conversational" classification, moving far beyond the squared circle to tackle everything from awkward FBI encounters at dinner to the polarizing culture of modern tipping. Nash provides a rare glimpse into his personal life, sharing recent health updates and detailing his surprisingly athletic "strongman" approach to household chores during his downtime. The episode takes a sharp turn into the world of professional sports and international intrigue, offering a blend of gritty realism and high-level analysis. The hosts dive deep into the staggering statistics of NCAA athletes making it to the NBA before shifting gears to analyze the tense geopolitical climate surrounding Iran. Nash pulls no punches as he critiques global leadership and reflects on the importance of respect and perspective in high-stakes situations, drawing parallels between street-level survival and international diplomacy. Wrestling fans are treated to expert breakdowns of the current landscape as the industry hurtles toward its biggest weekend of the year. Nash and Oliver dissect recent high-profile promos from stars like Cody Rhodes and CM Punk, debating the psychology behind "white meat" babyfaces and the necessity of "gaga" in building a main event. Between reflections on the legacy of Wilt Chamberlain and a lighthearted "Mount Nashmore" of television's greatest cops, this episode offers the signature blend of wisdom, wit, and unfiltered honesty that defines the show. Mando -Control Body Odor ANYWHERE with @shop.mando and get 20% off + free shipping with promo code KLIQ at shopmando.com! #mandopod BlueChew-Right now, when you buy two months of BlueChew Gold, you get the third for FREE with promo code NASH. Visit BlueChew.com for more details and important safety information, and we thank BlueChew for sponsoring the podcast. RAYCON- Grab a pair of Raycon's Essential Open Earbuds for 15% off today by using code KLIQOPEN at buyraycon.com.  00:00 Kliq This #197: Clarity-a 06:02 the problem with 5 stars 12:26 Shula's restaurant 16:49 Re sealing Wine 19:34 Nash has Kidney Problems? 24:36 Plaque scan 26:19 VERT BJ or cheese? 27:33 MICHIGAN 31:01 How many go pro? 36:53 Attending an NBA game 40:30 BREAK MANDO 46:05 our advertisers LOVE US 49:15 Wilt Chamberlin 54:33 The Mars Volta 55:39 Nash understands Psychology 58:01 Oliver Nash ALL DAY 59:06 Bad Drivers 01:07:10 Will you sign Wilt Chamberlin's book? 01:07:53 DPs in film 01:09:31 Microwave 01:10:52 KTTV 01:11:30 "Destroy Civilization" FEEEZE+ "backup network" 01:12:39 TECHNICAL DIFFICULTIES 01:13:57 The TWEET 01:23:04 Iran's Religios Idealogy 01:33:09 Waiting to see if the world stays turning 01:36:24 Lebanon 01:39:44 This is all about Gase prices 01:43:00 Pam Bondi 01:43:52 CM Punk's promo 01:44:31 CM Punk and Cody Rhodes Promos 01:46:20 Pat McAfee ADDS something 01:55:00 Brock Lesnar NEEDS to lose to Oba Femi 01:56:53 Mt Nashmore TV cops 02:01:29 BREAK BLUECHEW 02:04:46 Does Cody Turn Heel? Does Heyman turn on Brock? 02:05:56 College Basketball moments 02:07:21 COCAINE 02:07:40 JJ IRL 02:08:38 Gimmick Battle Royal 02:09:40 OUTRO      

McGrath spends £100 on a mystery box and is stunned by the first item he opens! Also, we talk about the moon, burgers and horrible textures.

A January 6th rioter has been sentenced to four years in prison for possessing child sexual assault material. Judge Mehta allows the civil suit against Trump for January 6th to proceed.   Two insurrectionists tried to intervene in Harry's lawsuit over the January 6th Plaque. Jared Wise is OUT at the Department of Justice.  Plus, former January 6th prosecutors have filed a brief in support of Representative LaMonica McIver. https://harrydunnformd.com/ Thank you, DeleteMe Go to joindeleteme.com/CLEANUP, and enter code CLEANUP at checkout for 20% off your DeleteMe plan. Allison Gillhttps://muellershewrote.substack.com/https://bsky.app/profile/muellershewrote.comHarry DunnHarry Dunn | Substack@libradunn1.bsky.social on BlueskyWant to support this podcast and get it ad-free and early?Go to: https://www.patreon.com/aisle45podTell us about yourself and what you like about the show - http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=short Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Description: Learn why advocating for care is crucial when moderate to severe plaque psoriasis develops at a young age or in high-impact sites, and how advanced biologic therapies can offer effective solutions for those that may be undertreated. Join moderator Kaitlin Walden, patient advocate Carolyn, and dermatologist Dr Candrice Heath as they discuss the realities of living with moderate to severe plaque psoriasis at a young age, as well as adult patients with plaque psoriasis in high-impact sites, like the scalp, nails, and face. Carolyn shares her personal journey with moderate to severe plaque psoriasis and how it has continued from childhood into adulthood, while Dr Heath offers insights to help caregivers and patients navigate treatment approaches, including when and how a biologic therapy may be helpful. This episode addresses challenges associated with living and treating moderate to severe plaque psoriasis in children and adults. This episode is sponsored by Johnson & Johnson. Please see Important Safety Information and full Prescribing Information for the product mentioned in this episode. Timestamps: ·       (0:23) Intro to Psoriasis Uncovered and guest introductions from dermatologist Dr. Candrice Heath and Carolyn, a patient advocate living with plaque psoriasis and psoriatic arthritis. ·       (1:22) Information about, and pivotal data for, TREMFYA® (guselkumab), a biologic used to treat adults and children 6 years and older who weigh at least 88 lbs or 40 kilograms with moderate to severe plaque psoriasis. ·       (3:48) Living with psoriasis as a child can be difficult with challenges in being diagnosed correctly and receiving appropriate treatment.  ·       (6:17) A dermatologist's view of children and adolescents living with plaque psoriasis including in high-impact sites. ·       (8:14) It's important to advocate for yourself and the best possible care. ·       (9:37) Open communication with your dermatologist helps identify the best possible treatment plan, which is dependent on several factors including the availability of new treatment options. ·       (12:05) Carolyn's biggest challenge is managing her psoriasis and then psoriatic arthritis. ·       (14:20) Results of the SPECTREM clinical trial addressing treatment of adults with moderate plaque psoriasis in high-impact sites. ·       (17:38) Find the support and information you need to find the right treatment. ·       (21:48) Important Safety Information about TREMFYA® (guselkumab).   Key Takeaways: ·       Plaque psoriasis can be challenging both physically and emotionally for children and adults – especially when high-impact site involvement (such as the face, scalp, armpits, and groin) is present. ·       Individual treatment plans vary and are based on several factors, including the severity of psoriasis, dosing schedule, cost, or route of administration. Finding the right treatment for plaque psoriasis is a collaboration between a dermatologist, the patient, and/or family (should the patient be a child). ·       A number of medicines that treat plaque psoriasis from the inside out, including biologics, are now available for children and adults. Such treatment options are continuing to expand. Guest Bios: Candrice Heath, M.D. is a highly respected triple board-certified dermatologist who sees both children and adults at Howard University Hospital in Washington DC where she is also an Associate Professor in the Department of Dermatology. She is board-certified in dermatology, pediatrics, and pediatric dermatology.  Dr Heath is a nationally recognized speaker, pediatric and adult dermatology clinical researcher, and has held a variety of leadership roles including Chair for the Pediatric Dermatology Research Alliance (PeDRA), Skin of Color and Pigmentary Disorders Focused Group, Skin of Color Society National Secretary-Treasurer, and American Academy of Dermatology Diversity Committee member. Her clinical, research, and teaching interests are shaped by insights gained from her unique practice filled with both children and adults in addition to her passion for exploring the intersection of dermatology and social science.  Carolyn Pugh is a patient advocate and volunteer with the National Psoriasis Foundation who lives with psoriasis and psoriatic arthritis. Carolyn was diagnosed with psoriasis at age 11 after being misdiagnosed and offered treatments that didn't work. Once she was diagnosed with plaque psoriasis some of the initial treatments were difficult and unsustainable. Over the years she has learned to advocate for her own self-care and feels her personal experiences can help empower other adults and parents. Resources: ·       Learn more about treatment options for children and adolescents at Our Spot for Youth and Parents   ·       For more information about psoriasis in high-impact sites

Dr. Hoffman continues his conversation with Dr. William Levine, a board-certified periodontist and chief scientist at Peri Active Oral Rinse.

Oral Health, Inflammation, and Periodontal Disease: Dr. William Levine, a board-certified periodontist and chief scientist at Peri Active Oral Rinse, offers a deep-dive on periodontal disease as an infectious inflammatory condition with autoimmune-like tissue destruction. It affects over 50% of U.S. adults over 35 and rises with age. He details bidirectional links between gum disease and systemic conditions, including cardiovascular disease, stroke, diabetes, and some dementias, and notes signs such as bleeding, pain, swelling, loose or shifting teeth, and gum recession. Levine explains plaque, dysbiosis, and biofilms, emphasizing mechanical plaque removal to preserve a healthy oral microbiome. Standard care includes scaling and root planing, possible surgery, and lasers; antiseptic rinses like chlorhexidine can be harsh and limited against biofilms. Levine describes a plant-bioactive rinse (gotu kola, echinacea, elderberry) designed to reduce harmful bacteria, penetrate gums, lower inflammation, and promote repair; xylitol may help via saliva stimulation. He also addresses smoking, dry mouth, fluoride toothpaste, interdental cleaning, and osteoporotic drugs' dental risks.

Support the show:https://www.paypal.me/Truelifepodcast?locale.x=en_USOne on One Video Call W/George https://tidycal.com/georgepmonty/60-minute-meeting# Transforming Adversity into Growth: Insights from Adam ButlerDiscover how Adam Butler transformed his life through adversity and psychedelics. Learn the key insights from his journey and how you can apply them to your own life.In a world where many feel lost and overwhelmed, the journey of Adam Butler serves as a beacon of hope. After experiencing a profound midlife crisis at 40, Adam recalibrated his life, delving into the realms of psychedelics and self-discovery. In this blog post, we explore his insights shared during an inspiring conversation on the True Life podcast, highlighting how embracing adversity can lead to a transformative journey.

This week, Madison's Office of the Independent Police Monitor released a new annual report detailing staffing issues in its office and calling for officers to wear body cameras. However, after some scrutiny about AI use, the report was taken down for further review. Host Bianca Martin talks with executive producer Hayley Sperling and newsletter editor Rob Thomas about the story. They also talk about the 27 animal activists who were arrested after breaking into Ridglan Farms and the removal of a marker on an Indigenous burial mound. Mentioned on the show: Effigy Mounds in Madison [City Cast Madison] Actress Alexandra Paul among animal rights activists arrested [Milwaukee Journal Sentinel] Our interview with police chief John Patterson [

In this episode of Curiosity Killed the Plaque, Spring Hatfield, RDH, BSPH, looks at oral health and pregnancy.Like this show? Leave us a review on your favorite podcasting app!Need CE? Start earning CE credits today at ⁠⁠⁠⁠https://rdh.tv/ce⁠⁠⁠⁠ Get daily dental hygiene articles at ⁠⁠⁠⁠https://www.todaysrdh.com⁠⁠⁠⁠ Follow Today's RDH on Facebook: ⁠⁠⁠⁠https://www.facebook.com/TodaysRDH/⁠⁠⁠⁠Follow Kara RDH on Facebook: ⁠⁠⁠⁠https://www.facebook.com/DentalHygieneKaraRDH/⁠⁠⁠⁠Follow Kara RDH on Instagram: ⁠⁠⁠⁠https://www.instagram.com/kara_rdh/⁠

Your Daily Lowdown from HELLO! Learn more about your ad choices. Visit megaphone.fm/adchoices

Today marks 25 years for Al with the company...he wants a plaque To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Depuis 24h, des images de Donald Trump avec une large plaque rouge au cou ont suscité beaucoup de questions dans les médias, et sur les réseaux sociaux. Notre journaliste santé Agathe Landais a montré ces clichés à des dermatologues pour comprendre ce dont souffre le Président américain. Ecoutez Ça va beaucoup mieux avec Jimmy Mohamed avec Agathe Landais du 04 mars 2026.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3308: Dr. Neal Malik explains why atherosclerosis can persist even with statins, diet, and lifestyle changes, highlighting the role of genetics, particularly elevated lipoprotein(a), in stubborn plaque buildup. His guidance emphasizes practical strategies like targeted fat choices, fiber intake, and realistic exercise plans to help reduce risk and prevent further progression. Quotes to ponder: "The trouble is, once this plaque, or atherosclerosis, sets in, it's not reversible through lifestyle alone." "It's estimated that about 1 in 5 Americans have high levels of lipoprotein-a." "Fiber is so helpful because it binds to cholesterol and helps the body get rid of it." Episode references: Omega-3 Fatty Acids – NIH Office of Dietary Supplements: https://ods.od.nih.gov/factsheets/Omega3FattyAcids-Consumer/ Learn more about your ad choices. Visit megaphone.fm/adchoices

Discover all of the podcasts in our network, search for specific episodes, get the Optimal Living Daily workbook, and learn more at: OLDPodcast.com. Episode 3308: Dr. Neal Malik explains why atherosclerosis can persist even with statins, diet, and lifestyle changes, highlighting the role of genetics, particularly elevated lipoprotein(a), in stubborn plaque buildup. His guidance emphasizes practical strategies like targeted fat choices, fiber intake, and realistic exercise plans to help reduce risk and prevent further progression. Quotes to ponder: "The trouble is, once this plaque, or atherosclerosis, sets in, it's not reversible through lifestyle alone." "It's estimated that about 1 in 5 Americans have high levels of lipoprotein-a." "Fiber is so helpful because it binds to cholesterol and helps the body get rid of it." Episode references: Omega-3 Fatty Acids – NIH Office of Dietary Supplements: https://ods.od.nih.gov/factsheets/Omega3FattyAcids-Consumer/ Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of Curiosity Killed the Plaque, Spring Hatfield, RDH, BSPH, looks at oral health and pregnancy.Like this show? Leave us a review on your favorite podcasting app!Need CE? Start earning CE credits today at ⁠⁠⁠https://rdh.tv/ce⁠⁠⁠ Get daily dental hygiene articles at ⁠⁠⁠https://www.todaysrdh.com⁠⁠⁠ Follow Today's RDH on Facebook: ⁠⁠⁠https://www.facebook.com/TodaysRDH/⁠⁠⁠Follow Kara RDH on Facebook: ⁠⁠⁠https://www.facebook.com/DentalHygieneKaraRDH/⁠⁠⁠Follow Kara RDH on Instagram: ⁠⁠⁠https://www.instagram.com/kara_rdh/⁠

In this episode of the Heart podcast, Digital Media Editor Professor James Rudd is joined by Dr Craig Balmforth from the University of Edinburgh. They discuss the rationale for identifying high-risk plaque, how imaging can help, and emerging therapies, including PCI. If you enjoy the show, please leave us a positive review wherever you get your podcasts. It helps us to reach more people - thanks! Link to published paper: https://heart.bmj.com/content/112/1/13.long

Full Show Notes: bengreenfieldlife.com/497 Welcome to another solo episode. This week I kick things off sharing my most effective hair health strategies, from nutrition and hormones to unique tools like derma rolling, red light therapy, and even topical caffeine—plus, why genetics aren’t your whole hair story. I break down a fascinating new study showing how magnesium holds the key to actually making your vitamin D work for you. I reveal why the length and intensity of your walking sessions matter more than you think, and how longer walking bouts can trump simply chasing that 10,000-step goal. I also revisit a forgotten but powerful heart-protective hack—adding pomegranate juice to your routine to help reduce arterial plaque and lower your blood pressure. To top it off, I share my wildest recent experiment: getting infusions of young human plasma in the name of anti-aging, breaking down the science of why it works and what I noticed firsthand. Episode Sponsors: Just Thrive: Just Thrive Probiotic is the only probiotic clinically proven to arrive 100% alive in your gut, wrestling in less bloat, better energy, and even clear skin. Digestive Bitters packs 12 science-backed herbs in one tasteless capsule that jumpstarts your digestion and supports GLP-1 production so cravings don’t control you. Visit justthrivehealth.com/BEN and save 20% with promo code BEN. See the difference for yourself or get a full product refund, no questions asked. LVLUP Health: I trust and recommend LVLUP Health for your peptide needs as they third-party test every single batch of their peptides to ensure you’re getting exactly what you pay for and the results you’re after! Head over to lvluphealth.com/BGL and use code BEN15 for a special discount on their game-changing range of products. Timeline: Give your cells new life with high-performance products powered by Mitopure, Timeline's powerful ingredient that unlocks a precise dose of the rare Urolithin A molecule and promotes healthy aging. Go to shop.timeline.com/BEN and use code BEN to get 20% off your order. Young Goose: To experience the transformative power of Young Goose's cutting-edge products, visit younggoose.com and use code BEN10 at checkout to enjoy a 10% discount on your first order. TRIUMPH Coaching: Join me for one-on-one coaching with me and my hand-picked team, custom-built around your labs, your lifestyle, and goals, until you actually hit them. No guesswork. Just results. If you’re finally ready to stop wasting time and money and start living the boundless life you know is possible, go to jointriumphcoaching.com and book your call.See omnystudio.com/listener for privacy information.

In this episode, Dr. Jockers shares the top seven foods to help clear arterial plaque, lower blood pressure, and reduce heart disease risk. He explains how nutrients like omega-3s, magnesium, and antioxidants play a crucial role in maintaining a healthy cardiovascular system.   You'll learn about the powerful benefits of wild-caught salmon, extra virgin olive oil, and pomegranates for supporting heart health and reducing plaque buildup. Dr. Jockers emphasizes the importance of nutrient-dense, low-toxin foods for optimal artery function.   Dr. Jockers also discusses how vitamins K2, D, and magnesium work together to prevent calcium from accumulating in the arteries, helping to keep your heart in top shape. These foods are essential for anyone looking to reduce their heart disease risk naturally. In This Episode:  00:00 Introduction to Heart Health 03:16 Understanding Artery Health 05:34 Top Artery Cleansing Foods 08:20 Pomegranate Benefits 10:06 Additional Heart-Healthy Foods 13:51 Cooking Tips for Heart Health 14:57 Conclusion and Farewell   If you want to burn belly fat…boost your energy levels…balance blood sugar…or relieve swelling in your legs or feet… Then you need to check out PureHealth Research immediately.   This company makes some amazing health-boosting supplements that are manufactured right here in America. They only use natural, non-GMO ingredients that are backed by the latest science and proven to work.   And right now, you can save 35% on all of their products with this special subscriber-only offer. Just use your exclusive coupon code JOCKERS at checkout.     Fuel your body with PaleoValley's grass-fed meat sticks, the ultimate healthy snack packed with protein and healthy fats to stabilize blood sugar and satisfy cravings. Made without sugar, additives, or preservatives, these meat sticks are perfect for on-the-go, guilt-free snacking. Choose from flavorful options like original summer sausage, garlic, teriyaki, and jalapeno, in both grass-fed beef and pasture-raised turkey. With an optimal omega-6 to omega-3 ratio, these snacks help reduce inflammation and support immune health, energy, and radiant skin. Ready to try? Visit paleovalley.com/jockers for a 15% discount on PaleoValley today!     "Pomegranates contain powerful antioxidants like anthocyanins and oleic acid that help reduce plaque in arteries and support heart health."  ~ Dr. Jockers     Subscribe to the podcast on: Apple Podcast Stitcher Spotify PodBean TuneIn Radio     Resources: Save 35% on premium health supplements with code JOCKERS at checkout. Visit purehealthresearch.com. Visit paleovalley.com/jockers for a 15% discount      Connect with Dr. Jockers: Instagram – https://www.instagram.com/drjockers/ Facebook – https://www.facebook.com/DrDavidJockers YouTube – https://www.youtube.com/user/djockers Website – https://drjockers.com/ If you are interested in being a guest on the show, we would love to hear from you! Please contact us here! - https://drjockers.com/join-us-dr-jockers-functional-nutrition-podcast/ 

In this episode of Sisterhood of S.W.E.A.T., Linda Mitchell sits down with Dr. John Osborne, board-certified cardiologist, lipidologist, and founder of Clear Cardio, to challenge conventional thinking around cholesterol and heart disease. Dr. Osborne explains why LDL cholesterol alone is not a reliable standalone marker for cardiovascular disease and why focusing only on traditional lab numbers can create a false sense of security. He shares how plaque can quietly develop for decades before symptoms appear — and why the first symptom for many people is a heart attack or sudden cardiac event. The conversation explores the evolution of cardiac imaging, the role of ApoB and lipoprotein(a) in risk assessment, and how advanced cardiac CT combined with artificial intelligence now allows physicians to detect, measure, and track plaque in ways that were previously impossible. This episode reframes heart disease as something that can be identified early — and potentially prevented — when the right tools are used. What We Talk About in This Episode Why LDL cholesterol alone does not tell the full story The difference between risk factors and actual disease How ApoB improves cardiovascular risk assessment Why lipoprotein(a) is genetic and should be tested at least once The limits of traditional stress testing How plaque forms in the arterial wall decades before symptoms Calcium scoring versus full cardiac CT imaging How AI is transforming plaque detection and measurement Whether arterial plaque can be slowed or reversed The real role of statins and other cholesterol-lowering tools Why you cannot out-train genetics The one scan adults over 40 should consider Quotes from This Episode Cholesterol floating in your bloodstream does not tell me if it is sticking. Risk is not disease. The first question should be: do you have plaque? Half of men and two-thirds of women, their first symptom of heart disease is a heart attack or death. The problem is not that we cannot treat plaque. The problem is that we are not looking for it early enough. Early detection for heart disease should be as routine as screening for cancer. Connect with Dr. John Osborne Clear Cardio https://clearcardio.com Clear Cardio – Powers of Prevention YouTube Channel https://www.youtube.com/@ClearCardio Learn more about Cardiac CT and AI plaque analysis https://clearcardio.com/services/ Contact and Locations (Texas, Chicago, expanding to New York) https://clearcardio.com/contact/  

On July 20, 1944, Stauffenberg and others risked everything to oppose Hitler, sacrificing their lives for justice and moral principle, reminding us that some values surpass life itself.

Today, I'm joined by the deeply thoughtful and refreshingly honest Dr. Sanjay Bhojraj, a self-described "curious cardiologist" who spent decades treating heart attacks in the cath lab — before stepping away to ask a bigger question: Why are we waiting for the crisis instead of preventing it?   Episode Timestamps: Welcome to Longevity & episode setup … 00:00:00 Dr. Bhojraj's shift from ER cardiology to prevention … 00:06:30 Why most heart attacks aren't caused by big blockages … 00:09:15 Stress, nervous system load & heart attack risk … 00:13:10 CIMT explained: what it measures (and what it misses) … 00:26:40 Calcium scores vs CT angiograms … 00:35:45 CLEERLY scan: seeing dangerous soft plaque … 00:38:45 Can plaque actually regress? … 00:41:55 When heart scans make patients less afraid … 00:44:05 When should you test — even without symptoms? … 00:45:50 Why age 45 is a major cardiovascular inflection point … 00:47:10 Hormones, estrogen loss & women's heart risk … 00:50:10 Why cardiology still misunderstands women … 00:54:30 Small dense LDL, ApoB & oxidized cholesterol … 01:02:00 Why fixing inflammation matters more than numbers … 01:05:50   Our Amazing Sponsors: Regenerive - Built around clinically validated Longufera (Ash X4) to support core aging pathways—so it's not just "healthy aging" in theory. Go to regenerive.co and use code NAT25 to save 25%   Mitopure® Longevity Gummies are the only clinically proven Urolithin A gummies supporting mitochondrial health — one of the key hallmarks of aging. Get 35% off a one-month subscription at Timeline.com/Nat2026 *Special deal through January 2026.   PW1 by Puori — A clean, high-quality whey protein that's third-party tested for over 200 contaminants and smooth enough to feel like a treat while supporting muscle, metabolism, and bone strength. Go to puori.com/NAT and use code NAT for 32% off your first subscription or 20% off anything on the site.   Nat's Links:  YouTube Channel Join My Membership Community Sign up for My Newsletter  Instagram  Facebook Group

Harry talks about lethal force training.The Senate voted by unanimous consent to display the January 6th Plaque. Trump is seeking $6.2M in attorney fees and costs over the Fulton County prosecution against him.An insurrectionist is running for office in Florida.Plus, the alleged pipe bomber has pled not guilty, though half of his indictment may be outside the statute of limitations. Go to joindeleteme.com/CLEANUP, and enter code CLEANUP at checkout for 20% off your DeleteMe plan. Allison Gillhttps://muellershewrote.substack.com/https://bsky.app/profile/muellershewrote.comHarry DunnHarry Dunn | Substack@libradunn1.bsky.social on BlueskyWant to support this podcast and get it ad-free and early?Go to: https://www.patreon.com/aisle45podTell us about yourself and what you like about the show - http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=short Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The trail for Milwaukee Judge Hanna Dugan has begun.The government has moved to dismiss the lawsuit brought to hang the January 6th Plaque.We have a new filing in the Hunter Biden and Patrick Byrne saga.Plus, a CBS Special Report on our friend Danny Hodges and some guy named Harry Dunn. Allison Gillhttps://muellershewrote.substack.com/https://bsky.app/profile/muellershewrote.comHarry DunnHarry Dunn | Substack@libradunn1.bsky.social on BlueskyWant to support this podcast and get it ad-free and early?Go to: https://www.patreon.com/aisle45podTell us about yourself and what you like about the show - http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=short Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.